Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2015 Financial Results Conference Call
SAN DIEGO, March 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company's fourth quarter and full year 2015 …